High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study.
Fiche du document
2012
- doi: 10.1016/j.nmd.2011.10.019
- issn: 0960-8966
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.nmd.2011.10.019
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/22153487
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1873-2364
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_DC240AF4B1D31
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Muscle Musculature Myodynamics Myology Death--Philosophy Dying End of lifeCiter ce document
K. Wahbi et al., « High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study. », Serveur académique Lausannois, ID : 10.1016/j.nmd.2011.10.019
Métriques
Partage / Export
Résumé
To determine incidence and type of major cardiac adverse events in patients with mutated desmin (DES) gene, we retrospectively reviewed baseline medical information, and examined the long-term outcomes of 28 DES patients (17 men, baseline mean age=37.7±14.4 years [min=9, max=71]) from 19 families. Baseline studies revealed skeletal muscle involvement in 21 patients and cardiac abnormalities in all but one patient. Over a mean follow-up of 10.4±9.4 years [min=1, max=35], cardiac death occurred in three patients, death due to cardiac comorbidities in two, one or more major cardiac adverse events in 13 patients. Among the 19 patients with mild conduction defects at baseline, eight developed high-degree conduction blocks requiring permanent pacing. Cardiac involvement was neither correlated with the type of DES mutation nor with the severity of skeletal muscle involvement. Our study underscores that in DES patients in-depth cardiac investigations are needed to prevent cardiac conduction system disease.